Please login to the form below
Venezuela
This page shows the latest Venezuela news and features for those working in and with pharma, biotech and healthcare.
Takeda gets EU green light for oral myeloma drug
Ninlaro is already available in the US, Canada, Israel, Australia and Venezuela, and has been filed in other markets including Japan.
Latest news
-
Takeda expands Latin American footprint
Headquartered in Lima, Takeda Peru adds to the company's existing operations in Brazil, Argentina, Mexico, Venezuela, Colombia and Ecuador.
-
The reed that bends: pharma needs to adapt to cultural sensitivities
IMS Health's 2012 report into 'pharmemerging' markets identified Argentina, Venezuela, Mexico and Turkey among the 17 fastest-growing developing nations.
-
Survey reveals the real impact of hayfever
458 children) from eight countries; Argentina, Brazil, Chile, Colombia, Ecuador, Mexico, Peru and Venezuela.
More from news
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest Intelligence
-
The MISTs of time - new emerging markets
However, it anticipates Mexico will be overtaken by both Argentina and Venezuela in the same period.
-
Current development and marketing of biosimilar monoclonal antibodies in Latin America
5) Partnership with Human Bioscience established on July 2012 for commercialization in Colombia, Venezuela, Ecuador and Peru.}.
-
Unfolding the biosimilar landscape in Latin America
Countries like Colombia, which is on the cusp of publishing its guidelines, Venezuela, Peru or Ecuador have yet to reach a similar development status, while some smaller countries have yet to
-
Positive prospects for pharma in Latin America
Venezuela is now the third largest and the fastest growing market in the Latin American continent growing at about 20 per cent. ... In Mexico, Venezuela and Peru, public healthcare coverage is broadening, which will benefit the pharmaceutical industry.
-
Country report: The healthcare market in Brazil
cent for Venezuela.
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
You’re sitting on a time bomb, so think harder and give more!
Constant inflation is not an option unless we’re planning to follow the economic models of Venezuela or Sudan, 1180% and 340% respectively.
-
Interactive infographic: LATAM
The LATAM region's largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region.
-
Infographic: LATAM
Latin America. The LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region.
More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- FDA external report recommends actions to address US opioid crisis
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Inizio appoints Stefanie Christmas as global head of DE&I
- Rare diseases: not so rare after all
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
- Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
- Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group
PMHub
The Creative Engagement Group
We create experiences that inspire lasting change. Exceptional experiences that engage people, change mindsets and behaviour, enrich cultures, increase skills...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
